Evidence map›Paper›PMID 27924011›Full record

ArticleNucleic acids research2016

Roles for APRIN (PDS5B) in homologous recombination and in ovarian cancer prediction.

Anthony M Couturier, Hubert Fleury, Anne-Marie Patenaude, Victoria L Bentley, Amélie Rodrigue, Yan Coulombe, Joshi Niraj, Joris Pauty, Jason N Berman, Graham Dellaire and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Clinical,medRxiv : the preprint server for health sciences · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chromosome architecture and homologous recombination in meiosis.Frontiers in cell and developmental biology · 2022
    Review
  14. Review
  15. RAD51 paralog function in replicative DNA damage and tolerance.Current opinion in genetics & development · 2021
    Review
  16. Article
  17. Cohesin Mutations in Cancer: Emerging Therapeutic Targets.International journal of molecular sciences · 2021
    Review
  18. Article
  19. PDS5A and PDS5B in Cohesin Function and Human Disease.International journal of molecular sciences · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Anthony M CouturierGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Axis, 9 McMahon, Québec City, QC G1R 2J6, Canada.
Hubert FleuryCentre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Canada; Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada.
Anne-Marie PatenaudeInstitut de Recherches Cliniques de Montréal and Department of Medicine, Université de Montréal, Montréal, Québec H2W 1R7, Canada.
Victoria L BentleyDalhousie University, Faculty of Medicine, Department of Pathology, Halifax, NS B3H 4R2, Canada.
Amélie RodrigueGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Axis, 9 McMahon, Québec City, QC G1R 2J6, Canada.
Yan CoulombeGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Axis, 9 McMahon, Québec City, QC G1R 2J6, Canada.
Joshi NirajGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Axis, 9 McMahon, Québec City, QC G1R 2J6, Canada.
Joris PautyGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Axis, 9 McMahon, Québec City, QC G1R 2J6, Canada.
Jason N BermanDalhousie University, Faculty of Medicine, Departments of Microbiology and Immunology, Pediatrics and Pathology, Halifax, NS B3H 4R2, Canada.
Graham DellaireDalhousie University, Faculty of Medicine, Department of Pathology, Halifax, NS B3H 4R2, Canada.
Javier M Di NoiaInstitut de Recherches Cliniques de Montréal and Department of Medicine, Université de Montréal, Montréal, Québec H2W 1R7, Canada.
Anne-Marie Mes-MassonCentre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Canada; Institut du cancer de Montréal, Montréal, QC H2X 0A9, Canada.
Jean-Yves MassonGenome Stability Laboratory, CHU de Québec Research Center, HDQ Pavilion, Oncology Axis, 9 McMahon, Québec City, QC G1R 2J6, Canada Jean-Yves.Masson@fmed.ulaval.ca.
Université Laval · CADalhousie University · CAUniversité de Montréal · CACentre Hospitalier de l’Université de Montréal · CAMontreal Clinical Research Institute · CA

Funding

CIHR MOP-130535
6 · The paper itself

Abstract

APRIN (PDS5 cohesin associated factor B) interacts with both the cohesin complex and the BRCA2 tumor suppressor. How APRIN influences cohesion and DNA repair processes is not well understood. Here, we show that APRIN is recruited to DNA damage sites. We find that APRIN interacts directly with RAD51, PALB2 and BRCA2. APRIN stimulates RAD51-mediated DNA strand invasion. APRIN also binds DNA with an affinity for D-loop structures and single-strand (ss) DNA. APRIN is a new homologous recombination (HR) mediator as it counteracts the RPA inhibitory effect on RAD51 loading to ssDNA. We show that APRIN strongly improves the annealing of complementary-strand DNA and that it can stimulate this process in synergy with BRCA2. Unlike cohesin constituents, its depletion has no impact on class switch recombination, supporting a specific role for this protein in HR. Furthermore, we show that low APRIN expression levels correlate with a better survival in ovarian cancer patients and that APRIN depletion sensitizes cells to the PARP inhibitor Olaparib in xenografted zebrafish. Our findings establish APRIN as an important and specific actor of HR, with cohesin-independent functions.

Indexed as

AdultAgedAged, 80 and overAnimalsAntineoplastic AgentsBenzimidazolesBiomarkers, TumorBRCA2 ProteinCell Line, TumorDNA-Binding ProteinsDNA DamageDrug Resistance, NeoplasmFanconi Anemia Complementation Group N ProteinFemaleHumansKaplan-Meier EstimateAntineoplastic AgentsBenzimidazolesBiomarkers, TumorBRCA2 ProteinBRCA2 protein, humanDNA-Binding ProteinsFanconi Anemia Complementation Group N ProteinNuclear ProteinsolaparibPALB2 protein, humanPDS5B protein, humanPhthalazinesPiperazinesRAD51 protein, humanRad51 RecombinaseTranscription FactorsTumor Suppressor Proteinsveliparib

Identifiers

PMID27924011
PMCPMC5159559
OpenAlexW2537747792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.